serw-MX  [xml]  
 


    
 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.092 Adenosine Deaminase Inhibitors .
D27.505.519.389.275 Cholinesterase Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.085 Angiotensin-Converting Enzyme Inhibitors .
D27.505.519.389.745.085.500 Vasopeptidase Inhibitors .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.750 Sodium Channel Blockers .
D27.505.519.562.750.100 Acid Sensing Ion Channel Blockers .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.120 Cholinergic Agents .
D27.505.519.625.120.300 Cholinesterase Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.120 Cholinergic Agents .
D27.505.696.577.120.300 Cholinesterase Inhibitors .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Angiotensin-Converting Enzyme Inhibitors .
Angiotensin I-Converting Enzyme Inhibitors .
Angiotensin-Converting Enzyme Antagonists .
Antagonists, Angiotensin-Converting Enzyme .
Antagonists, Kininase II .
Inhibitors, ACE .
Inhibitors, Angiotensin-Converting Enzyme .
Inhibitors, Kininase II .
Kininase II Antagonists .
Angiotensin Converting Enzyme Antagonists .
Angiotensin Converting Enzyme Inhibitors .
Angiotensin I Converting Enzyme Inhibitors .
Antagonists, Angiotensin Converting Enzyme .
Enzyme Antagonists, Angiotensin-Converting .
Enzyme Inhibitors, Angiotensin-Converting .
Inhibitors, Angiotensin Converting Enzyme .
Kininase II Inhibitors .
ACE Inhibitors .
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. .
1.00
 
Vasopeptidase Inhibitors .
ACE-NEP Inhibitors .
NEP-ACE Inhibitors .
ACE NEP Inhibitors .
NEP ACE Inhibitors .
A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II. .
0.83
 
/antagonists & inhibitors .
/antagonists and inhibitors .
/antagonists .
/inhibitors .
Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. .
0.83
 
Adenosine Deaminase Inhibitors .
ADA Inhibitors .
Deaminase Inhibitors, Adenosine .
Inhibitors, ADA .
Inhibitors, Adenosine Deaminase .
Drugs that inhibit ADENOSINE DEAMINASE activity. .
0.73
 
Acid Sensing Ion Channel Blockers .
ASIC Blockers .
ASIC Channel Antagonists .
ASIC Channel Blockers .
ASIC Inhibitors .
Acid Sensing Ion Channel Inhibitors .
Antagonists, ASIC Channel .
Blockers, ASIC Channel .
Channel Antagonists, ASIC .
Channel Blockers, ASIC .
Proton Gated Sodium Channel Blockers .
Proton-Gated Sodium Channel Blockers .
A subclass of sodium channel blockers that are specific for ACID-SENSING SODIUM CHANNELS. .
0.71
 
Cholinesterase Inhibitors .
Anti-Cholinesterases .
Anticholinesterase Drugs .
Anticholinesterases .
Cholinesterase Inhibitors, Irreversible .
Cholinesterase Inhibitors, Reversible .
Agents, Anticholinesterase .
Anti Cholinesterases .
Drugs, Anticholinesterase .
Inhibitors, Acetylcholinesterase .
Inhibitors, Cholinesterase .
Inhibitors, Irreversible Cholinesterase .
Inhibitors, Reversible Cholinesterase .
Irreversible Cholinesterase Inhibitors .
Reversible Cholinesterase Inhibitors .
Acetylcholinesterase Inhibitors .
Anticholinesterase Agents .
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. .
0.71